BlackRock, acting on behalf of clients and funds, has declared to the AMF that on January 20 it crossed downwards the threshold of 5% of Arkema's capital and held, on behalf of said clients and funds, 4.98% of the chemical company's capital and 3.98% of its voting rights.

The American asset management giant explained that this threshold crossing was the result of an off-market sale of Arkema shares and a reduction in the number of shares held as collateral.

Copyright (c) 2025 CercleFinance.com. All rights reserved.